Preclinical Safety Evaluation of Recombinant Human Interleukin-10

Author： Rosenblum I.Y.   Johnson R.C.   Schmahai T.J.  

Publisher： Elsevier

ISSN： 0273-2300

Source： Regulatory Toxicology and Pharmacology, Vol.35, Iss.1, 2002-02, pp. : 56-71

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic and Biodistribution Profile of Recombinant Human Interleukin-10 Following Intravenous Administration in Rats with Extensive Liver Fibrosis

By Rachmawati Heni   Beljaars Leonie   Reker-Smit Catharina   Van Loenen-Weemaes Anne-miek M.   Hagens Werner I.   Meijer Dirk K. F.   Poelstra Klaas  

Pharmaceutical Research, Vol. 21, Iss. 11, 2004-11 ,pp. : 2072-2078

Springer Publishing Company

Access to resources Recommend Favorite

Pre-Clinical Safety Evaluation of Antimicrobial Bioadhesive Vaginal Formulations

By  

Anti-Infective Agents, Vol. 14, Iss. 1, 2016-04 ,pp. : 23-27

Bentham Science Publishers

Access to resources Recommend Favorite

Interleukin-10

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 5, Iss. 3, 2006-08 ,pp. : 223-231

Bentham Science Publishers

Access to resources Recommend Favorite

Preclinical Investigation of the Safety of Eplir

By Saratikov A.   Livshits N.   Burchenkova F.   Kadychagova N.   Novozheeva T.   Akhmedzhanov R.   Perevozchikova T.   Bashirova L.  

Pharmaceutical Chemistry Journal, Vol. 39, Iss. 2, 2005-02 ,pp. : 64-66

Springer Publishing Company

Access to resources Recommend Favorite

Effect of cordycepin on interleukin-10 production of human peripheral blood mononuclear cells

By Zhou X.   Meyer C.U.   Schmidtke P.   Zepp F.  

European Journal of Pharmacology, Vol. 453, Iss. 2, 2002-10 ,pp. : 309-317

Elsevier

Access to resources Recommend Favorite